[go: up one dir, main page]

Kaijzel et al., 2007 - Google Patents

Whole-body optical imaging in animal models to assess cancer development and progression

Kaijzel et al., 2007

Document ID
479150794508506673
Author
Kaijzel E
van Der Pluijm G
Lowik C
Publication year
Publication venue
Clinical Cancer Research

External Links

Snippet

Different optical-based imaging models were used to investigate tumor progression and metastasis with particular emphasis on metastasis to bone and bone marrow. We describe how optical imaging can be used to follow important processes in tumor development and …
Continue reading at aacrjournals.org (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group the fluorescent group being a small organic molecule
    • A61K49/0032—Methine dyes, e.g. cyanine dyes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0058—Antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0056—Peptides, proteins, polyamino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using infra-red, visible or ultra-violet light
    • G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64—Fluorescence; Phosphorescence
    • G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"

Similar Documents

Publication Publication Date Title
Kaijzel et al. Whole-body optical imaging in animal models to assess cancer development and progression
Lyons Advances in imaging mouse tumour models in vivo
Bremer et al. Optical-based molecular imaging: contrast agents and potential medical applications
O'Neill et al. Bioluminescent imaging: a critical tool in pre‐clinical oncology research
Zhang et al. Phosphorescent light–emitting iridium complexes serve as a hypoxia-sensing probe for tumor imaging in living animals
Hoffman Green fluorescent protein imaging of tumour growth, metastasis, and angiogenesis in mouse models
Imamura et al. In vivo optical imaging of cancer cell function and tumor microenvironment
Winnard Jr et al. Noninvasive optical tracking of red fluorescent protein-expressing cancer cells in a model of metastatic breast cancer
Vooijs et al. Noninvasive imaging of spontaneous retinoblastoma pathway-dependent tumors in mice
Condeelis et al. In vivo imaging in cancer
Afshari et al. Self-illuminating NIR-II bioluminescence imaging probe based on silver sulfide quantum dots
Henriquez et al. Advances in optical imaging and novel model systems for cancer metastasis research
Ning et al. A proof-of-concept application of water-soluble ytterbium (III) molecular probes in in vivo NIR-II whole body bioimaging
Chen et al. Long-term monitoring of intravital biological processes using fluorescent protein-assisted NIR-II imaging
Lyons et al. Imaging mouse cancer models in vivo using reporter transgenes
Xie et al. Dual-wavelength imaging of tumor progression by activatable and targeting near-infrared fluorescent probes in a bioluminescent breast cancer model
Hoffman Advantages of multi-color fluorescent proteins for whole-body and in vivo cellular imaging
Bremer et al. In vivo imaging of gene expression: MR and optical technologies
Zhang et al. Near-infrared dye-labeled anti-prostate stem cell antigen minibody enables real-time fluorescence imaging and targeted surgery in translational mouse models
Li et al. Self-illuminating agents for deep-tissue optical imaging
Lyons et al. Noninvasive bioluminescence imaging of normal and spontaneously transformed prostate tissue in mice
Hollingshead et al. A potential role for imaging technology in anticancer efficacy evaluations
Gompels et al. In vivo optical imaging in arthritis—an enlightening future?
Servais et al. Animal models and molecular imaging tools to investigate lymph node metastases
Guo et al. A fluorescent,[18F]-Positron-Emitting agent for imaging prostate-specific membrane antigen allows genetic reporting in adoptively transferred, genetically modified cells